Multinational firms opposing new drug pricing policy

Published: 2011-07-22 06:59:00

Updated: 2011-07-22 06:59:00

The government’s controversial policies to cut drug pricing have been criticized by multinational drug manufacturer here as “rationale-lacking ones.”

The Korean Research-based Pharmaceutical Industry Association (KRPIA) said in a statement that multinational and domestic drug makers are both c...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK